Stocks Spike On Yet Another Remdesivir Press Release Tyler Durden Fri, 07/10/2020 08.54 Shortly after PPI disappointed and Fed’s Kaplan warned of dis inflation, the markets spiked higher apparently on the heels of yet another press release by Gilead claiming a 62% reduction in mortality rates vs ‘standard care’ with its Remdesivir COVID treatment

Stocks Spike On Yet Another Remdesivir Press Release Tyler Durden Fri, 07/10/2020 08.54 Shortly after PPI disappointed and Fed’s Kaplan warned of dis inflation, the markets spiked higher apparently on the heels of yet another press release by Gilead claiming a 62% reduction in mortality rates vs ‘standard care’ with its Remdesivir COVID treatment

encouraging